Abstract
Keywords
References
Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice. Protein losing enteropathy in children. Eur J Pediatr. 2010;169:1179–85.
Zlatkina AR. Chronic enteropathy: pathogenesis and treatment strategy. Quality of the life. Moscow: Meditsina; 2004;5.
Umar SB, DiBaise JK. Protein-losing enteropathy: case illustrations and clinical review. Am J Gastroenterol. 2010;105(1):43–49.
Proujansky R. Protein-losing enteropathy. In: Walker WA, Goulet OJ, Kleinman RE, Sanderson IR, Sherman PM, Shneider BL, editors. Pediatric gastrointestinal disease. Ontario: BC Decker
Inc; 2004: 194–202.
Greenwald D. Protein-losing gastroenteropathy. In: Feldman M, Friedman LS, Brandt LJ, Sleisinger MH, editors. Gastrointestinal and liver disease. Philadelphia: Saunders; 2006.
Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann’s disease). Orphanet J Rare Dis. 2008;22:3–5.
Suresh N, Ganesh R, Sankar J, Sathiyasekaran M. Primary intestinal lymphangiectasia. Indian Pediatr. 2009;46(10):903–6.
Hokari R, Kitagawa N, Watanabe C, Komoto S, Kurihara C, Okada Y, et al. Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss. J Gastroenterol Hepatol. 2008;23:e88–e95.
Klempa I. A therapeutic trial of somatostatin (Serono) in surgery of the pancreas. Data on file. 1981.
???????? ??, ???????? ??. ????????? ? ????????????? ?????????????????. ???. 2003; 3.
http://www.pharm-sintez.ru/ links/ContOk.htm
Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med. 2001;28:836–46.
Lam JC, Aters S, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Ther. 2001;8:409–15.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.